These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12513698)

  • 61. Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding.
    Bot G; Blake AD; Li S; Reisine T
    J Neurochem; 1998 Jan; 70(1):358-65. PubMed ID: 9422382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
    Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine.
    Chakrabarti S; Law PY; Loh HH
    Brain Res Mol Brain Res; 1995 Jun; 30(2):269-78. PubMed ID: 7637578
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D; Raehal KM; Bilsky EJ; Sadée W
    J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
    Clark MJ; Linderman JJ; Traynor JR
    Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity.
    De Vries TJ; Tjon Tien Ril GH; Van der Laan JW; Mulder AH; Schoffelmeer AN
    Life Sci; 1993; 52(21):1685-93. PubMed ID: 8388977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization and distribution of a cloned rat mu-opioid receptor.
    Bunzow JR; Zhang G; Bouvier C; Saez C; Ronnekleiv OK; Kelly MJ; Grandy DK
    J Neurochem; 1995 Jan; 64(1):14-24. PubMed ID: 7798908
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation.
    Clark MJ; Furman CA; Gilson TD; Traynor JR
    J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
    Xu H; Lu YF; Rothman RB
    Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Zhang L; Walker EA; Sutherland J; Young AM
    Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
    Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
    Kovoor A; Celver JP; Wu A; Chavkin C
    Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The hypothesis that antagonism of fentanyl analgesia by 2-chloroprocaine is mediated by direct action on opioid receptors.
    Coda B; Bausch S; Haas M; Chavkin C
    Reg Anesth; 1997; 22(1):43-52. PubMed ID: 9010946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.